While the US presidential election result took some time to be determined, cannabis has been declared a big winner in the most recent American vote.
Matt Carr, chief trends strategist at the Oxford Club, spoke with the Investing News Network about the state of cannabis investment following a turbulent week of results from the race.
Joe Biden is now projected to become the next US president, defeating Donald Trump as the incumbent. Even though Biden hasn’t expressed full support for cannabis legalization, his running mate Kamala Harris has stood in favor of policy reform, which is expected to help the overall US cannabis industry.
Carr was speaking last Friday (November 6), before Biden’s victory was officially called by the media. While he wasn’t sure there would be an official election result anytime soon, he did feel the election already had a theme in place: cannabis.
Heading into the election last Tuesday (November 3), Carr — and the cannabis business community at large — was looking forward to the results for five state ballot measures that could legalize cannabis medically and recreationally. The five states voting were Arizona, Mississippi, Montana, New Jersey and South Dakota; in the end, all five measures cleared, representing more policy victories at the state level.
“That’s been great, that’s exactly what we wanted to see. Those five states have the opportunity to add as much as US$9 billion in new revenue between now and 2025,” Carr said.
Carr explained he was surprised to see stock market moves from Canadian cannabis companies given that these entities still can’t and won’t be able to tap into the US market in the near future.
“Those Canadian companies are really limited in their presence, but since those are the most actively traded because they trade on major US exchanges … those are where investors are turning for this kind of proxy on the results from those states,” he said.
In regards to the possibility of a sweeping federal legalization framework in the US under a Biden presidency, a move that could allow Canadian producers to enter into the gigantic market, Carr isn’t so sure it’ll be an immediate item for Biden and Harris to look into.
“I think you’re going to continue to make these inroads towards some change at the federal level; we already see at the state level that this is working,” Carr said. However, the expert said the success of the state markets makes him think the federal government may continue to leave policy up to individual states and allow for growth to come from that political movement.
Watch the video above to hear Carr’s full thoughts on the outlook for cannabis investments given the new US president. You can also click here for more cannabis videos on YouTube.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.
Meanwhile, two longstanding cannabis partners ended their relationship.
Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development
Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.
The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.
With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.
DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.